Charles River Laboratories | A Saját Tőke És A Tartalékok



Equity Capital And Reserves változás Dátum
Agilent USD 6.03B 129M 2025-01
Align Technology USD 3.85B 92.37M 2024-12
Bio-Rad Laboratories USD 6.57B 918.56M 2024-12
Bruker USD 1.8B 28M 2024-12
Cardinal Health USD -2991000000 286M 2024-12
Charles River Laboratories USD 3.46B 320.77M 2024-12
Cigna USD 41.03B 1.06B 2024-12
CVS Health USD 75.56B 616M 2024-12
Danaher USD 50.85B 1.31B 2025-03
Dentsply International USD 1.94B 549M 2024-12
Elevance Health USD 42.5B 1.19B 2025-03
Galapagos EUR 2.75B 149.05M 2025-03
Hologic USD 4.77B 356.7M 2024-12
Humana USD 16.38B 1.19B 2024-12
Illumina USD 2.37B 248M 2024-12
Incyte USD 3.67B 219.94M 2025-03
IQVIA Holdings USD 6.07B 900M 2024-12
Laboratory Of America USD 8.05B 118M 2024-12
Lonza CHF 9.33B 23M 2024-12
McKesson USD -3084000000 67M 2024-12
Merck EUR 29.99B 1.66B 2024-12
Mettler Toledo International USD -126890000 27.46M 2024-12
Novartis USD 44.05B 605M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Quest Diagnostics USD 6.93B 151M 2025-03
Revvity USD 7.64B 29.74M 2025-03
Thermo Fisher Scientific USD 49.36B 227M 2025-03
United Therapeutics USD 6.44B 343.1M 2024-12
UnitedHealth USD 100.81B 8.15B 2025-03
Walgreens Boots Alliance USD 7.11B 2.83B 2025-02
Waters USD 1.83B 225.41M 2024-12
West Pharmaceutical Services USD 2.68B 800K 2025-03



Charles River Laboratories A Saját Tőke És A Tartalékok - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Apr 2025.